Elevance Health Inc ELV

$439.95 -5.33 (-1.20%)

Valuation

Market cap
96,567,432,000
Revenue TTM
$199,125,000,000
Net income TTM
$5,662,000,000
PE ratio
14.30
Forward PE
14.97
Profit margin
2.84%
Debt to equity
0.69

Trading

Volume
1,173,800
Avg volume
1,183,902
Day's range
$439.00 – $445.42
Shares out
216,869,000
Stochastic %K
64%
Beta
0.70
Analysts
Strong Sell
Price target
$471.81

Price

Company profile

Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates in four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to individual, employer group risk-based and fee-based, BlueCard, Medicare, Medicaid, and FEP members; health products; a broad array of fee-based a...

Show more

Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates in four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to individual, employer group risk-based and fee-based, BlueCard, Medicare, Medicaid, and FEP members; health products; a broad array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, and supplemental health insurance benefits. The company also operates in the pharmacy services business; and markets and offers pharmacy services, including home delivery and specialty pharmacies, claims adjudication, formulary management, pharmacy networks, rebate administration, a prescription drug database, and member services, as well as infusion services and injectable therapies through ambulatory infusion centers. In addition, it provides healthcare related services and capabilities, including specialty care enablement and utilization management support for specialized clinical domains; behavioral health and comprehensive care management services; palliative care services and management; virtual care; and payment integrity, subrogation, clinical data exchange through its HealthOS platform, research and data, reporting and clinical analytics, information technology, and business process support services, as well as manages home health, post-acute institutional management, and durable medical equipment costs; and supports plans in managing home and community-based services. The company provides its services under the Anthem Blue Cross and Blue Shield, Wellpoint, and Carelon brands. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health, Inc. in June 2022. Elevance Health, Inc. was incorporated in 2001 and is based in Indianapolis, Indiana.

Industry
Healthcare Plans
Sector
Healthcare
Phone
833 401 1577
Website
https://www.elevancehealth.com
Address
220 Virginia Avenue, Indianapolis, United States

Latest news

Stocktwits

BigAllergies Oct 24, 11:11 AM
Elevance Health CFO Mark Kaye sold $4.7M of $ELV on Oct 22, per Form 4: getbreakaway.com/ELV
0 replies
AXLFI_HQ Oct 22, 11:19 PM
$ELV Healthcare-plan stocks are advancing broadly as enrollment normalization and better operating execution improve earnings expectations, with recent earnings beats reinforcing the recovery. Learn more: https://axlfi.com/themes/momentum/660
0 replies
Techdamentals Oct 22, 4:23 AM
$ELV raised its 2026 profit forecast to at least $29 a share from $27 on Wednesday Oct 21. Its third-quarter medical loss ratio (the share of premiums paid out for care) was 90.6% versus 91.17% expected. The Techdamentals IV Calculator range is below. What is it worth? 👇 https://techdamentals.com/v/ELV?ref=st Educational, not advice.
0 replies
TalkMarkets Oct 22, 4:12 AM
2 Healthcare Stocks To Buy After Crushing Q3 Earnings Expectations: ELV & ISRG $ISRG $ELV https://talkmarkets.com/article/2-healthcare-stocks-to-buy-after-crushing-q3-earnings-expectations-elv-isrg
0 replies
ddizzle09 Oct 21, 10:38 PM
$ELV that end of day dump was not a good sight
0 replies
filecrux Oct 21, 6:31 PM
$ELV Elevance Q3 EPS up 17.9% as investment income rose 65.9%; operating gain fell 2.0%.
0 replies
ddizzle09 Oct 21, 2:46 PM
$ELV nice recovery. Bought back my calls for a 70pct gain this morning thx
0 replies
CallYourMommy Oct 21, 2:26 PM 0 replies